Related references
Note: Only part of the references are listed.A reinforcing HNF4-SMAD4 feed-forward module stabilizes enterocyte identity
Lei Chen et al.
NATURE GENETICS (2019)
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
Talia Golan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Yingyao Zhou et al.
NATURE COMMUNICATIONS (2019)
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
J. Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Subtype-specific regulatory network rewiring in acute myeloid leukemia
Salam A. Assi et al.
NATURE GENETICS (2019)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
The molecular functions of hepatocyte nuclear factors - In and beyond the liver
Hwee Hui Lau et al.
JOURNAL OF HEPATOLOGY (2018)
Therapeutic developments in pancreatic cancer: current and future perspectives
John P. Neoptolemos et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer
Alison P. Klein et al.
NATURE COMMUNICATIONS (2018)
Functional role of BTB and CNC Homology 1 gene in pancreatic cancer and its association with survival in patients treated with gemcitabine
Xudong Huang et al.
THERANOSTICS (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Single and collective cell migration: the mechanics of adhesions
Chiara De Pascalis et al.
MOLECULAR BIOLOGY OF THE CELL (2017)
Metformin suppresses cancer initiation and progression in genetic mouse models of pancreatic cancer
Ke Chen et al.
MOLECULAR CANCER (2017)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
Expression of HNF4G and its potential functions in lung cancer
Jingyu Wang et al.
Oncotarget (2017)
(Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial
Michele Reni et al.
CLINICAL CANCER RESEARCH (2016)
An Ancient, Unified Mechanism for Metformin Growth Inhibition in C. elegans and Cancer
Lianfeng Wu et al.
CELL (2016)
Metformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson
Roongruedee Chaiteerakij et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Genomic analyses identify molecular subtypes of pancreatic cancer
Peter Bailey et al.
NATURE (2016)
Pancreatic cancer risk variant in LINC00673 creates a miR-1231 binding site and interferes with PTPN11 degradation
Jian Zheng et al.
NATURE GENETICS (2016)
ChIPseeker: an R/Bioconductor package for ChIP peak annotation, comparison and visualization
Guangchuang Yu et al.
BIOINFORMATICS (2015)
Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial
Sil Kordes et al.
LANCET ONCOLOGY (2015)
Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer
Erica J. Childs et al.
NATURE GENETICS (2015)
The selection and function of cell type-specific enhancers
Sven Heinz et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer
Brian M. Wolpin et al.
NATURE GENETICS (2014)
Measuring genetic interactions in human cells by RNAi and imaging
Christina Laufer et al.
NATURE PROTOCOLS (2014)
Metformin-mode of action and clinical implications for diabetes and cancer
Ida Pernicova et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
The role of tight junctions in cancer metastasis
Tracey A. Martin
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2014)
Tight junction proteins: From barrier to tumorigenesis
E. Aaron Runkle et al.
CANCER LETTERS (2013)
Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
Russell A. Miller et al.
NATURE (2013)
Genome-wide association study identifies common variants in SLC39A6 associated with length of survival in esophageal squamous-cell carcinoma
Chen Wu et al.
NATURE GENETICS (2013)
Mapping genetic interactions in human cancer cells with RNAi and multiparametric phenotyping
Christina Laufer et al.
NATURE METHODS (2013)
Orphan nuclear receptor HNF4G promotes bladder cancer growth and invasion through the regulation of the hyaluronan synthase 2 gene
T. Okegawa et al.
ONCOGENESIS (2013)
Balancing glycolytic flux: the role of 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatases in cancer metabolism
Susana Ros et al.
CANCER & METABOLISM (2013)
AMPK Promotes p53 Acetylation via Phosphorylation and Inactivation of SIRT1 in Liver Cancer Cells
Chi-Wai Lee et al.
CANCER RESEARCH (2012)
Pathway analysis of genome-wide association study data highlights pancreatic development genes as susceptibility factors for pancreatic cancer
Donghui Li et al.
CARCINOGENESIS (2012)
Metformin in cancer: translational challenges
Ryan J. O. Dowling et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2012)
Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations
Chen Wu et al.
NATURE GENETICS (2012)
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33
Gloria M. Petersen et al.
NATURE GENETICS (2010)
Genome-Wide Association Study of Pancreatic Cancer in Japanese Population
Siew-Kee Low et al.
PLOS ONE (2010)
New Users of Metformin Are at Low Risk of Incident Cancer A cohort study among people with type 2 diabetes
Gillian Libby et al.
DIABETES CARE (2009)
DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer
Christine A. Iacobuzio-Donahue et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer
Laufey Amundadottir et al.
NATURE GENETICS (2009)
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group
Malcolm J. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer
Nabeel Bardeesy et al.
GENES & DEVELOPMENT (2006)
Share Paper
